CHALFONT ST. GILES, UK –– GE Healthcare Life Sciences, (NYSE: GE) and Cellectis Group (Alternext: ALCLS), the global genome engineering specialist, announced today that GE Healthcare has licenced Cellectis to develop, manufacture and sell models derived from stem cells for use in drug discovery and toxicity screening. The agreement follows the announcement that GE Healthcare […]
Paris and Codolet, France – The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research. Through this Management Buy-Out (MBO) operation Cisbio Bioassays becomes independent, with its […]
Louvain-la-Neuve, Belgium – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the closing of the sale of 100% of its Business Unit Cisbio Bioassays. Today’s closing has led to a payment to IBA of EUR 16.3 million. In addition, the contract includes […]
St. Cloud, Minnesota, USA — Microbiologics, a leading global manufacturer of prepared quality control microorganism products, debuts its first molecular product line, Helix Elite™. These molecular standards are intended to facilitate the development, validation, and monitoring of molecular assays. The Helix Elite™ molecular product line currently includes 13 molecular standards for microorganisms that are difficult […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced SureFISH ALK, ROS1 and RET break-apart translocation probes, expanding its offering of oligonucleotide-based fluorescent in situ hybridization (FISH) products. Agilent now offers more than 450 FISH probes The majority of FISH probes available on the market use BAC technology. BAC probes target repeat regions, […]
WEST LAFAYETTE, Ind. – Purdue and GE have entered into a university-industry partnership that exemplifies a new approach to expediting the academia-based technology commercialization process. The agreement, signed this month, will merge the expertise of GE’s corporate technology commercialization group with innovations being developed at Purdue to commercialize new technologies. “GE already benefits from a […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate accomplishments. Third Quarter and Recent Corporate Accomplishments ? BioTime’s subsidiary, Asterias Biotherapeutics, Inc., completed its acquisition of […]
State College, PA — Salivary bioscience is emerging as a scientific field which is centered in the space between multiple disciplines. The number of analytes that can be measured in saliva is increasing rapidly. As measurement capabilities advance, more information can be gained from samples that are archived. Archiving saliva samples using the right tools […]
CARLSBAD, Calif. –– Life Technologies Corporation and The Jackson Laboratory (JAX) announced today an agreement enabling JAX to use Life’s Transcription Activator-Like Effector technology (TALs) to generate and market novel mouse disease models. Jackson Laboratory will also establish a program to maintain and distribute TAL-modified mice developed by researchers in pharma and academic labs. Life […]
VANCOUVER – STEMCELL Technologies announced today that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) will provide up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research as well as broader research in infectious disease. Despite significant progress in understanding […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
